Format
Sort by

Send to

Choose Destination

Search results

Items: 2

1.

Safety and Immunogenicity of EBA-175 RII-NG Malaria Vaccine Administered Intramuscularly in Semi-Immune Adults: A Phase 1, Double-Blinded Placebo Controlled Dosage Escalation Study.

Koram KA, Adu B, Ocran J, Karikari YS, Adu-Amankwah S, Ntiri M, Abuaku B, Dodoo D, Gyan B, Kronmann KC, Nkrumah F.

PLoS One. 2016 Sep 19;11(9):e0163066. doi: 10.1371/journal.pone.0163066. eCollection 2016.

2.

A systematic approach to stabilizing EBA-175 RII-NG for use as a malaria vaccine.

Peek LJ, Brandau DT, Jones LS, Joshi SB, Middaugh CR.

Vaccine. 2006 Jul 26;24(31-32):5839-51. Epub 2006 May 12.

PMID:
16735084

Supplemental Content

Loading ...
Support Center